Published ahead of print on April 2, 2003, doi:10.1164/rccm.200212-1424BC
Am. J. Respir. Crit. Care Med., Volume 168, Number 1, July 2003, 121-125
A more recent version of this article appeared on July 1, 2003
Submitted on December 6, 2002
Accepted on March 28, 2003
Maintenance Azithromycin Therapy for Bronchiolitis Obliterans Syndrome: Results of a Pilot Study
Susan G Gerhardt1, John F McDyer1, Reda E Girgis1, John V Conte2, Stephen C Yang3, and Jonathan B Orens1*
1 Medicine, Division of Pulmonary and Critical Care Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA,
2 Division of Cardiac Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA,
3 Division of Thoracic Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
* To whom correspondence should be addressed. E-mail: jorens{at}jhmi.edu.
Bronchiolitis obliterans syndrome remains the leading cause of morbidity and mortality in the pulmonary transplant population. Previous studies show that macrolide antibiotics may be efficacious in the treatment of panbronchiolitis and cystic fibrosis. In the later, azithromycin decreases the number of respiratory exacerbations, improves forced expiratory volume in one second, and improves quality of life. We hypothesized that oral azithromycin therapy may improve lung function in patients with bronchiolitis obliterans syndrome. To test this hypothesis, we conducted an open label pilot trial using maintenance azithromycin therapy in six lung transplant recipients (250 milligrams orally three times per week for a mean of 13.7 weeks). In this study, five of these six individuals demonstrated significant improvement in pulmonary function as assessed by forced expiratory volume in one second (FEV1), as compared to their baseline values at the start of azithromycin therapy. The mean increase in the percent of predicted FEV1 values in these individuals was 17.1% (p 0.05). Additionally, the absolute FEV1 increased by 0.50 liters (range -0.18 liters to 1.36 liters). These data suggest a potential role for maintenance macrolide therapy in the treatment of bronchiolitis obliterans syndrome in lung transplant recipients.
Key words: obliterative bronchiolitis, chronic rejection, macrolides, lung transplant
This article has been cited by other articles:

|
 |

|
 |
 
J. Gottlieb
Review: Update on lung transplantation
Therapeutic Advances in Respiratory Disease,
August 1, 2008;
2(4):
237 - 247.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Vanaudenaerde, R. Vos, N. Geudens, D. Van Raemdonck, L. Dupont, and G. Verleden
The Leuven experience with a dichotomy in Bronchiolitis Obliterans Syndrome (BOS) after lung transplantation revealed by azithromycin
Eur. Respir. Rev.,
June 1, 2008;
17(108):
93 - 95.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T J Williams and J W Wilson
Challenges in pulmonary fibrosis: 7 {middle dot} Novel therapies and lung transplantation
Thorax,
March 1, 2008;
63(3):
277 - 284.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Krolewiecki, H. D. Romero, S. P. Cajal, D. Abraham, T. Mimori, T. Matsumoto, M. Juarez, and N. J. Taranto
A Randomized Clinical Trial Comparing Oral Azithromycin and Meglumine Antimoniate for the Treatment of American Cutaneous Leishmaniasis Caused by Leishmania (Viannia) braziliensis
Am J Trop Med Hyg,
October 1, 2007;
77(4):
640 - 646.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. H. Walters, D. W. Reid, D. P. Johns, and C. Ward
Nonpharmacological and pharmacological interventions to prevent or reduce airway remodelling
Eur. Respir. J.,
September 1, 2007;
30(3):
574 - 588.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-F. Cordier
Challenges in pulmonary fibrosis {middle dot} 2 : Bronchiolocentric fibrosis
Thorax,
July 1, 2007;
62(7):
638 - 649.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. White and L. A. Ruth-Sahd
Bronchiolitis Obliterans Organizing Pneumonia
Crit. Care Nurse,
June 1, 2007;
27(3):
53 - 66.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. O. Soubani and J. P. Uberti
Bronchiolitis obliterans following haematopoietic stem cell transplantation
Eur. Respir. J.,
May 1, 2007;
29(5):
1007 - 1019.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Lloyd and D. S. Robinson
Allergen-induced airway remodelling
Eur. Respir. J.,
May 1, 2007;
29(5):
1020 - 1032.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Van Muylem, C. Knoop, and M. Estenne
Early Detection of Chronic Pulmonary Allograft Dysfunction by Exhaled Biomarkers
Am. J. Respir. Crit. Care Med.,
April 1, 2007;
175(7):
731 - 736.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. F. McDyer
Human and Murine Obliterative Bronchiolitis in Transplant
Proceedings of the ATS,
January 1, 2007;
4(1):
37 - 43.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Al-Githmi, N. Batawil, N. Shigemura, M. Hsin, T. W. lee, G.-W. He, and A. Yim
Bronchiolitis obliterans following lung transplantation
Eur. J. Cardiothorac. Surg.,
December 1, 2006;
30(6):
846 - 851.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kourlas
Anti-inflammatory Properties of Macrolide Antibiotics
Journal of Pharmacy Practice,
October 1, 2006;
19(5):
326 - 329.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Hodge, G. Hodge, S. Brozyna, H. Jersmann, M. Holmes, and P. N. Reynolds
Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages
Eur. Respir. J.,
September 1, 2006;
28(3):
486 - 495.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. Verleden, B. M. Vanaudenaerde, L. J. Dupont, and D. E. Van Raemdonck
Azithromycin Reduces Airway Neutrophilia and Interleukin-8 in Patients with Bronchiolitis Obliterans Syndrome
Am. J. Respir. Crit. Care Med.,
September 1, 2006;
174(5):
566 - 570.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. F. Angel, D. Levine, J. Sanchez, and S. Levine
Azithromycin in Bronchiolitis Obliterans: Is the Evidence Strong Enough?
Am. J. Respir. Crit. Care Med.,
February 15, 2006;
173(4):
465 - 466.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. B. Orens, J. F. McDyer, and R. E. Girgis
Azithromycin in Bronchiolitis Obliterans: Is the Evidence Strong Enough?
Am. J. Respir. Crit. Care Med.,
February 15, 2006;
173(4):
466 - 466.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Wilkes, T. M. Egan, and H. Y. Reynolds
Lung Transplantation: Opportunities for Research and Clinical Advancement
Am. J. Respir. Crit. Care Med.,
October 15, 2005;
172(8):
944 - 955.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Williams and G. M. Verleden
Azithromycin: A Plea for Multicenter Randomized Studies in Lung Transplantation
Am. J. Respir. Crit. Care Med.,
September 15, 2005;
172(6):
657 - 659.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Yates, D. M. Murphy, I. A. Forrest, C. Ward, R. M. Rutherford, A. J. Fisher, J. L. Lordan, J. H. Dark, and P. A. Corris
Azithromycin Reverses Airflow Obstruction in Established Bronchiolitis Obliterans Syndrome
Am. J. Respir. Crit. Care Med.,
September 15, 2005;
172(6):
772 - 775.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S C Bell, S L Senini, and J G McCormack
Macrolides in cystic fibrosis
Chronic Respiratory Disease,
April 1, 2005;
2(2):
85 - 98.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Khalid, A. Al Saghir, S. Saleemi, S. Al Dammas, M. Zeitouni, A. Al Mobeireek, N. Chaudhry, and E. Sahovic
Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: a preliminary study
Eur. Respir. J.,
March 1, 2005;
25(3):
490 - 493.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. Verleden, L. J. Dupont, and D. E. Van Raemdonck
Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal?
Eur. Respir. J.,
February 1, 2005;
25(2):
221 - 224.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. W. Amsden
Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
J. Antimicrob. Chemother.,
January 1, 2005;
55(1):
10 - 21.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Egan
Obliterative Bronchiolitis after Lung Transplantation: A Repetitive Multiple Injury Airway Disease
Am. J. Respir. Crit. Care Med.,
November 1, 2004;
170(9):
931 - 932.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Kotloff, V. N. Ahya, and S. W. Crawford
Pulmonary Complications of Solid Organ and Hematopoietic Stem Cell Transplantation
Am. J. Respir. Crit. Care Med.,
July 1, 2004;
170(1):
22 - 48.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Egan
The Clinical Practice of Lung Transplantation in North America
Chest,
April 1, 2004;
125(4):
1183 - 1184.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kanazawa, S. Nomura, M. Muramatsu, K. Yamaguchi, S. Fukuhara, S. G. Gerhardt, J. F. McDyer, R. J. Cummings, and J. B. Orens
Azithromycin and Bronchiolitis Obliterans
Am. J. Respir. Crit. Care Med.,
March 1, 2004;
169(5):
654 - 655.
[Full Text]
|
 |
|

|
 |

|
 |
 
M. J. Tobin
Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2003
Am. J. Respir. Crit. Care Med.,
January 15, 2004;
169(2):
301 - 313.
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 American Thoracic Society
|
|
|